Results 51 to 60 of about 19,645 (222)
Psychosocial and Biological Factors Contributing to Body Weight Gain in Schizophrenia [PDF]
Overweight and obesity are frequently reported to be a significant issue in schizophrenia resulting in the inherent complications of these disorders.
Pai, NB, Vella, SC
core +2 more sources
Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia? [PDF]
A diagnosis of schizophrenia, as in most of psychiatric practice, is made largely by eliciting symptoms with reference to subjective, albeit operationalized, criteria. This diagnosis then provides some rationale for management.
Achim +151 more
core +2 more sources
Maternal health remains a critical global concern, particularly in underserved populations and in low‐ and middle‐income countries where access to safe and effective therapeutics is limited. Despite the use of medications by most women during pregnancy, the exclusion of pregnant and lactating women from clinical trials has resulted in significant data ...
Rachel K. Scott +7 more
wiley +1 more source
The previous two decades have been marked by profound societal transformations, including ongoing developments in the illegal drug market and the emergence of numerous novel psychoactive substances.
Giovanni Martinotti +4 more
doaj +1 more source
ABSTRACT Objective Previous research has revealed negative effects of appearance‐related social media content, such as fitspiration, on body satisfaction. However, specific interventions to reduce these detrimental effects are scarce. Therefore, this randomized controlled pilot trial investigated the efficacy of the four‐week online intervention body ...
Gritt Ladwig +4 more
wiley +1 more source
Prevalence and risk factors for HIV, hepatitis B, and hepatitis C in people with severe mental illness: a total population study of Sweden [PDF]
BACKGROUND: Severe mental illness is associated with increased morbidity and mortality. The elevated risk of blood-borne viruses (BBVs) in people with severe mental illness is of concern, but the full extent of this problem is unclear.
Bauer-Staeb, C +5 more
core +1 more source
Abstract Objective To clinically validate the contribution of a custom‐built EEG wearable device (waEEG) compared to a full 10–20 electrode array ambulatory EEG (aEEG) for screening epilepsy cases in patients with suspected temporal lobe epilepsy (TLE) but negative routine EEGs. Methods Patients (aged 16–91 years) with clinically suspected TLE who were
Daniel Filipe Borges +4 more
wiley +1 more source
Pharmacotherapy in patients with epilepsy and psychosis. [PDF]
The recognition and treatment of psychosis in persons with epilepsy (PWE) is recommended with the apparent dilemma between treating psychosis and opening the possibility of exacerbating seizures. The pooled prevalence estimate of psychosis in PWE is 5.6%.
Adachi, N +9 more
core +1 more source
Abstract Objective To define and articulate research priorities in epilepsy identified by the European Reference Network for Rare and Complex Epilepsies (ERN EpiCARE), addressing key unmet needs across the spectrum of rare and complex epilepsies. Methods This position paper was developed through a structured collaborative process involving patient ...
Sébile Tchaicha +27 more
wiley +1 more source
Comorbidity of mental disorders and substance use: A brief guide for the primary care clinician [PDF]
Comorbidity or the co-occurrence of mental disorders and substance use disorders is common. However there are significant problems with the management of people with comorbidity and a dearth of evidence about best practice.
Holmwood, Chris
core

